Which has stronger earnings & valuation, HAWK or EVH?

HawkEye 360 has higher earnings, but lower revenue than Evolent Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HawkEye 360 $204.21M 9.77 N/A N/A N/A Evolent Health $1.89B 0.22 -$534.51M -$4.76 N/A

Does the media prefer HAWK or EVH?

In the previous week, Evolent Health had 5 more articles in the media than HawkEye 360. MarketBeat recorded 7 mentions for Evolent Health and 2 mentions for HawkEye 360. Evolent Health's average media sentiment score of 0.53 beat HawkEye 360's score of 0.34 indicating that Evolent Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HawkEye 360 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Evolent Health 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor EVH or FLYW?

In the previous week, Flywire had 2 more articles in the media than Evolent Health. MarketBeat recorded 9 mentions for Flywire and 7 mentions for Evolent Health. Flywire's average media sentiment score of 0.62 beat Evolent Health's score of 0.53 indicating that Flywire is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evolent Health 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Flywire 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer NEO or EVH?

In the previous week, NeoGenomics had 13 more articles in the media than Evolent Health. MarketBeat recorded 20 mentions for NeoGenomics and 7 mentions for Evolent Health. Evolent Health's average media sentiment score of 0.53 beat NeoGenomics' score of 0.46 indicating that Evolent Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeoGenomics 6 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Evolent Health 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, EVH or EVTC?

Evertec has lower revenue, but higher earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Evertec, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Evolent Health $1.89B 0.22 -$534.51M -$4.76 N/A Evertec $931.82M 2.09 $141.59M $2.07 15.26

Does the media favor EVH or EVTC?

In the previous week, Evertec had 2 more articles in the media than Evolent Health. MarketBeat recorded 9 mentions for Evertec and 7 mentions for Evolent Health. Evertec's average media sentiment score of 0.73 beat Evolent Health's score of 0.53 indicating that Evertec is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evolent Health 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Evertec 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, EVH or STGW?

Stagwell has higher revenue and earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Stagwell, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Evolent Health $1.89B 0.22 -$534.51M -$4.76 N/A Stagwell $2.91B 0.68 $29.10M $0.07 113.86

Does the media prefer EVH or STGW?

In the previous week, Evolent Health had 4 more articles in the media than Stagwell. MarketBeat recorded 7 mentions for Evolent Health and 3 mentions for Stagwell. Stagwell's average media sentiment score of 0.88 beat Evolent Health's score of 0.53 indicating that Stagwell is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evolent Health 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Stagwell 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Evolent Health (EVH) Competitors

$3.76 -0.06 (-1.44%)

Closing price 07/28/2026 03:59 PM Eastern

Extended Trading

$3.73 -0.03 (-0.72%)

As of 04:00 AM Eastern

Compare

EVH vs. HAWK, FLYW, NEO, EVTC, and STGW

Should you buy Evolent Health stock or one of its competitors? MarketBeat compares Evolent Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Evolent Health include HawkEye 360 (HAWK), Flywire (FLYW), NeoGenomics (NEO), Evertec (EVTC), and Stagwell (STGW). These companies are all part of the "business services" industry.

How does Evolent Health compare to HawkEye 360?

HawkEye 360 (NYSE:HAWK) and Evolent Health (NYSE:EVH) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, media sentiment, earnings and profitability.

HawkEye 360 has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market. Comparatively, Evolent Health has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market.

In the previous week, Evolent Health had 5 more articles in the media than HawkEye 360. MarketBeat recorded 7 mentions for Evolent Health and 2 mentions for HawkEye 360. Evolent Health's average media sentiment score of 0.53 beat HawkEye 360's score of 0.34 indicating that Evolent Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HawkEye 360	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Evolent Health	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

90.7% of HawkEye 360 shares are held by institutional investors. 3.8% of HawkEye 360 shares are held by company insiders. Comparatively, 1.5% of Evolent Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

HawkEye 360 presently has a consensus price target of $36.89, indicating a potential upside of 81.09%. Evolent Health has a consensus price target of $6.16, indicating a potential upside of 64.07%. Given HawkEye 360's stronger consensus rating and higher probable upside, analysts clearly believe HawkEye 360 is more favorable than Evolent Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HawkEye 360	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.90
Evolent Health	2 Sell rating(s)	4 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.53

HawkEye 360 has higher earnings, but lower revenue than Evolent Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HawkEye 360	$204.21M	9.77	N/A	N/A	N/A
Evolent Health	$1.89B	0.22	-$534.51M	-$4.76	N/A

HawkEye 360 has a net margin of 0.00% compared to Evolent Health's net margin of -26.29%. Evolent Health's return on equity of 0.36% beat HawkEye 360's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HawkEye 360	N/A	N/A	N/A
Evolent Health	-26.29%	0.36%	0.10%

Summary

Evolent Health beats HawkEye 360 on 8 of the 15 factors compared between the two stocks.

How does Evolent Health compare to Flywire?

Evolent Health (NYSE:EVH) and Flywire (NASDAQ:FLYW) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk, earnings and dividends.

In the previous week, Flywire had 2 more articles in the media than Evolent Health. MarketBeat recorded 9 mentions for Flywire and 7 mentions for Evolent Health. Flywire's average media sentiment score of 0.62 beat Evolent Health's score of 0.53 indicating that Flywire is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Evolent Health	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Flywire	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Evolent Health presently has a consensus target price of $6.16, indicating a potential upside of 64.07%. Flywire has a consensus target price of $18.69, indicating a potential upside of 12.88%. Given Evolent Health's higher probable upside, research analysts clearly believe Evolent Health is more favorable than Flywire.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evolent Health	2 Sell rating(s)	4 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.53
Flywire	0 Sell rating(s)	7 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.53

Flywire has lower revenue, but higher earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Flywire, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evolent Health	$1.89B	0.22	-$534.51M	-$4.76	N/A
Flywire	$623.03M	3.28	$13.50M	$0.23	72.00

Evolent Health has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market. Comparatively, Flywire has a beta of 1.32, suggesting that its stock price is 32% more volatile than the broader market.

95.9% of Flywire shares are owned by institutional investors. 1.5% of Evolent Health shares are owned by insiders. Comparatively, 5.0% of Flywire shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Flywire has a net margin of 4.45% compared to Evolent Health's net margin of -26.29%. Flywire's return on equity of 3.78% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evolent Health	-26.29%	0.36%	0.10%
Flywire	4.45%	3.78%	2.61%

Summary

Flywire beats Evolent Health on 13 of the 16 factors compared between the two stocks.

How does Evolent Health compare to NeoGenomics?

NeoGenomics (NASDAQ:NEO) and Evolent Health (NYSE:EVH) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, media sentiment, dividends, earnings, institutional ownership and risk.

98.5% of NeoGenomics shares are owned by institutional investors. 1.1% of NeoGenomics shares are owned by insiders. Comparatively, 1.5% of Evolent Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

NeoGenomics has higher earnings, but lower revenue than Evolent Health. NeoGenomics is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeoGenomics	$745.97M	2.34	-$108.03M	-$0.77	N/A
Evolent Health	$1.89B	0.22	-$534.51M	-$4.76	N/A

In the previous week, NeoGenomics had 13 more articles in the media than Evolent Health. MarketBeat recorded 20 mentions for NeoGenomics and 7 mentions for Evolent Health. Evolent Health's average media sentiment score of 0.53 beat NeoGenomics' score of 0.46 indicating that Evolent Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeoGenomics	6 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Evolent Health	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

NeoGenomics has a beta of 1.74, indicating that its stock price is 74% more volatile than the broader market. Comparatively, Evolent Health has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

NeoGenomics presently has a consensus price target of $14.57, suggesting a potential upside of 8.74%. Evolent Health has a consensus price target of $6.16, suggesting a potential upside of 64.07%. Given Evolent Health's stronger consensus rating and higher probable upside, analysts plainly believe Evolent Health is more favorable than NeoGenomics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeoGenomics	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.42
Evolent Health	2 Sell rating(s)	4 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.53

NeoGenomics has a net margin of -13.30% compared to Evolent Health's net margin of -26.29%. Evolent Health's return on equity of 0.36% beat NeoGenomics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeoGenomics	-13.30%	-2.80%	-1.72%
Evolent Health	-26.29%	0.36%	0.10%

Summary

Evolent Health beats NeoGenomics on 9 of the 16 factors compared between the two stocks.

How does Evolent Health compare to Evertec?

Evolent Health (NYSE:EVH) and Evertec (NYSE:EVTC) are both small-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends.

Evolent Health has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market. Comparatively, Evertec has a beta of 0.71, indicating that its share price is 29% less volatile than the broader market.

Evertec has lower revenue, but higher earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Evertec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evolent Health	$1.89B	0.22	-$534.51M	-$4.76	N/A
Evertec	$931.82M	2.09	$141.59M	$2.07	15.26

In the previous week, Evertec had 2 more articles in the media than Evolent Health. MarketBeat recorded 9 mentions for Evertec and 7 mentions for Evolent Health. Evertec's average media sentiment score of 0.73 beat Evolent Health's score of 0.53 indicating that Evertec is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Evolent Health	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Evertec	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Evolent Health currently has a consensus price target of $6.16, indicating a potential upside of 64.07%. Evertec has a consensus price target of $32.75, indicating a potential upside of 3.71%. Given Evolent Health's stronger consensus rating and higher probable upside, research analysts plainly believe Evolent Health is more favorable than Evertec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evolent Health	2 Sell rating(s)	4 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.53
Evertec	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

96.8% of Evertec shares are owned by institutional investors. 1.5% of Evolent Health shares are owned by insiders. Comparatively, 1.1% of Evertec shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Evertec has a net margin of 13.95% compared to Evolent Health's net margin of -26.29%. Evertec's return on equity of 31.40% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evolent Health	-26.29%	0.36%	0.10%
Evertec	13.95%	31.40%	9.36%

Summary

Evertec beats Evolent Health on 10 of the 16 factors compared between the two stocks.

How does Evolent Health compare to Stagwell?

Evolent Health (NYSE:EVH) and Stagwell (NASDAQ:STGW) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations and media sentiment.

Evolent Health presently has a consensus target price of $6.16, suggesting a potential upside of 64.07%. Stagwell has a consensus target price of $7.80, suggesting a potential downside of 2.13%. Given Evolent Health's stronger consensus rating and higher possible upside, analysts clearly believe Evolent Health is more favorable than Stagwell.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evolent Health	2 Sell rating(s)	4 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.53
Stagwell	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

Evolent Health has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market. Comparatively, Stagwell has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market.

35.6% of Stagwell shares are owned by institutional investors. 1.5% of Evolent Health shares are owned by company insiders. Comparatively, 11.2% of Stagwell shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Stagwell has a net margin of 0.64% compared to Evolent Health's net margin of -26.29%. Stagwell's return on equity of 24.12% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evolent Health	-26.29%	0.36%	0.10%
Stagwell	0.64%	24.12%	4.31%

Stagwell has higher revenue and earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Stagwell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evolent Health	$1.89B	0.22	-$534.51M	-$4.76	N/A
Stagwell	$2.91B	0.68	$29.10M	$0.07	113.86

In the previous week, Evolent Health had 4 more articles in the media than Stagwell. MarketBeat recorded 7 mentions for Evolent Health and 3 mentions for Stagwell. Stagwell's average media sentiment score of 0.88 beat Evolent Health's score of 0.53 indicating that Stagwell is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Evolent Health	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Stagwell	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Stagwell beats Evolent Health on 12 of the 16 factors compared between the two stocks.

Get Evolent Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EVH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EVH vs. The Competition

Export

Metric	Evolent Health	INTERNET SOFTWARE Industry	Computer Sector	NYSE Exchange
Market Cap	$428.55M	$17.19B	$37.14B	$23.66B
Dividend Yield	N/A	1.71%	3.18%	4.20%
P/E Ratio	-0.79	68.20	75.80	31.08
Price / Sales	0.22	36.31	596.20	14.27
Price / Cash	0.81	78.24	43.69	31.92
Price / Book	1.06	6.58	8.96	4.83
Net Income	-$534.51M	$385.08M	$1.08B	$1.07B
7 Day Performance	-32.59%	3.71%	-1.00%	0.69%
1 Month Performance	-34.64%	1.57%	-3.91%	0.89%
1 Year Performance	-60.03%	-15.99%	132.54%	15.67%

Evolent Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EVH Evolent Health	3.3978 of 5 stars	$3.76 -1.4%	$6.16 +64.1%	-61.0%	$428.55M	$1.89B	N/A	4,200	Analyst Forecast High Trading Volume
HAWK HawkEye 360	4.3096 of 5 stars	$19.33 -5.7%	$38.38 +98.5%	N/A	$2.01B	$204.21M	N/A	403	Analyst Forecast
FLYW Flywire	3.3357 of 5 stars	$15.89 -1.5%	$18.69 +17.6%	+42.0%	$1.99B	$623.03M	69.09	1,400	Upcoming Earnings
NEO NeoGenomics	1.6636 of 5 stars	$13.89 -2.5%	$14.57 +4.9%	+107.4%	$1.85B	$727.33M	N/A	2,500	Trending News Earnings Report
EVTC Evertec	3.9591 of 5 stars	$29.72 +2.2%	$32.75 +10.2%	-4.7%	$1.79B	$931.82M	14.36	5,327	Upcoming Earnings Dividend Announcement

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:EVH) was last updated on 7/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Evolent Health (EVH) Competitors

EVH vs. HAWK, FLYW, NEO, EVTC, and STGW

How does Evolent Health compare to HawkEye 360?

Summary

How does Evolent Health compare to Flywire?

Summary

How does Evolent Health compare to NeoGenomics?

Summary

How does Evolent Health compare to Evertec?

Summary

How does Evolent Health compare to Stagwell?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EVH vs. The Competition

Evolent Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Evolent Health (EVH) Competitors

EVH vs. HAWK, FLYW, NEO, EVTC, and STGW

How does Evolent Health compare to HawkEye 360?

Which has more risk and volatility, HAWK or EVH?

Does the media prefer HAWK or EVH?

Do insiders and institutionals have more ownership in HAWK or EVH?

Do analysts rate HAWK or EVH?

Which has stronger earnings & valuation, HAWK or EVH?

Is HAWK or EVH more profitable?

Summary

How does Evolent Health compare to Flywire?

Does the media favor EVH or FLYW?

Do analysts rate EVH or FLYW?

Which has preferable earnings & valuation, EVH or FLYW?

Which has more risk & volatility, EVH or FLYW?

Do insiders & institutionals believe in EVH or FLYW?

Is EVH or FLYW more profitable?

Summary

How does Evolent Health compare to NeoGenomics?

Do insiders and institutionals hold more shares of NEO or EVH?

Which has preferable valuation & earnings, NEO or EVH?

Does the media prefer NEO or EVH?

Which has more risk and volatility, NEO or EVH?

Do analysts rate NEO or EVH?

Is NEO or EVH more profitable?

Summary

How does Evolent Health compare to Evertec?

Which has more risk & volatility, EVH or EVTC?

Which has stronger earnings & valuation, EVH or EVTC?

Does the media favor EVH or EVTC?

Do analysts recommend EVH or EVTC?

Do institutionals and insiders have more ownership in EVH or EVTC?

Is EVH or EVTC more profitable?

Summary

How does Evolent Health compare to Stagwell?

Do analysts prefer EVH or STGW?

Which has more volatility & risk, EVH or STGW?

Do institutionals and insiders hold more shares of EVH or STGW?

Is EVH or STGW more profitable?

Which has higher valuation and earnings, EVH or STGW?

Does the media prefer EVH or STGW?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EVH vs. The Competition

Evolent Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools